USFDA completes GMP inspection of Dr Reddy's Middleburgh facility in New York
Dr Reddys Laboratories announced that the United States Food & Drug Administration (USFDA) completed a GMP inspection at its API Middleburgh facility in New York. The inspection was conducted from 12th May, 2025 to 16th May, 2025 (US EST time). The company has been issued a Form 483 with 2 observations.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
5 hours ago
- News18
Sacheerome IPO Allotment In Focus Today: A Step-By-Step Guide To Check Status Online, Know GMP
Last Updated: The allotment of the Sacheerome IPO, which received a whopping 312.94 times subscription, will be finalised today, June 12. The latest GMP indicates 47.06% listing gains. Sacheerome IPO Allotment Today: The Sacheerome IPO allotment is set to be finalised today, June 12, in the evening. After the basis of allotment is finalised, investors will start receiving bank debit messages. They can also check the allotment status online on the websites of BSE and NSE, as well as on registrar Link Intime's portal. Here's the latest GMP, as well as a step-by-step guide to check allotment status. The Sacheerome IPO was open for public subscription between June 9 and June 11. On the final day of bidding on Wednesday, the Rs 61.62-crore NSE SME IPO received a whopping 312.94 times subscription, garnering bids for 1,25,76,46,800 shares as against 40,18,800 shares on offer. The retail and NII participation stood at 180.28 times and 808.56 times, respectively. The qualified institutional buyers (QIB) category has received a 173.15 times subscription so far. Sacheerome IPO: A Step-By-Step Guide To Check Allotment Status The Sacheerome IPO allotment will take place on Thursday, June 12. The IPO allotment status can be checked online by following these steps: 1) Go to the official BSE website via the URL — 2) Under 'Issue Type', select 'Equity'. 3) Under 'Issue Name', select 'Sacheerome Ltd' in the dropbox. 4) Enter your application number, or the Permanent Account Number (PAN). 5) Then, click on the 'I am not a robot' to verify yourself and hit the 'Search' option. You can also visit directly on the registrar Link Intime's portal — and check the Sacheerome IPO allotment status. The allotment status can also be checked on the NSE's website at Sacheerome IPO GMP Today & Listing Date According to market observers, unlisted shares of Sacheerome Ltd are currently trading at Rs 150 apiece in the grey market, which is a 47.06% premium or GMP over the IPO price of Rs 102. It indicates decent listing gains for investors on June 16, the tentative listing date. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Listing Date: Shares of Sacheerome Ltd are scheduled to be listed on the NSE's SME platform on June 16. Sacheerome IPO: More Details The Sacheerome IPO, which is a bookbuilding of Rs 61.62 crore, is entirely a fresh issue of 60.41 lakh shares. The price of the IPO was fixed at Rs 102 per share. The minimum lot size for an application was 1,200. The minimum amount of investment required by retail investors was Rs 1,22,400. The bidding could be done in multiple of 1,200. The public offer was opened for subscription on June 9, 2025, and closed on June 11, 2025. The allotment for the Sacheerome IPO is expected to be finalised on Thursday, June 12, 2025. It will be list on the NSE SME with a tentative listing date fixed as Monday, June 16, 2025. About Sacheerome Ltd Sacheerome Limited, founded in June 1992, designs and manufactures fragrances and flavours for B2B FMCG clients in India and globally. Its fragrances cater to sectors like personal care, home care, and wellness, while its flavours serve beverages, bakery, dairy, nutrition, oral care, and more. Location : New Delhi, India, India First Published: June 12, 2025, 06:35 IST News business » ipo Sacheerome IPO Allotment In Focus Today: A Step-By-Step Guide To Check Status Online, Know GMP
Business Standard
2 days ago
- Business Standard
Nifty ends near flatline; IT shares in demand
The key equity indices ended sideways today, as investors kept a close eye on ongoing US-China trade discussions and varied global indicators. The Nifty ended above the 25,100 level. IT, media and pharma shares advanced, while realty, PSU bank and private bank shares declined. As per provisional closing data, the S&P BSE Sensex shed 53.49 points or 0.06% to 82,391.72. The Nifty 50 index rose 1.05 points or 0.00% to 25,104.25. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.04% and the S&P BSE Small-Cap index added 0.33%. The market breadth was positive. On the BSE, 2,246 shares rose and 1,793 shares fell. A total of 133 shares were unchanged. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, tanked 4.61% to 14.02. Buzzing Index: The Nifty IT index rose 1.67% to 38,299.95. The index rose 4.14% in the five consecutive trading sessions. Oracle Financial Services Software (up 3.91%), Persistent Systems (up 2.69%), Mphasis (up 2.63%), LTIMindtree (up 2.51%), Tech Mahindra (up 2.14%), Coforge (up 2.03%), HCL Technologies (up 1.37%), Wipro (up 1.35%), Infosys (up 1.34%) and Tata Consultancy Services (up 1.2%) advanced. Stocks in Spotlight: Jindal Saw surged 6.68% after announcing board approval for three overseas investments worth up to $118 million, aimed at expanding its footprint in the Middle Easts iron and steel industry. Cinevista hit an upper limit of 20% after the company announced that its board will meet on Thursday, 12 June 2025, to review updates related to its joint development venture with K Raheja Corp Real Estate. ITD Cementation India soared 6.10% after the company secured a contract worth Rs 893 crore for the construction of Berth & Breakwater for the development of Greenfield Captive Jetty(s) in Odisha. OneSource Specialty Pharma rose 5% after the company announced that its flagship drug-device combination facility in Bangalore has retained its compliance status with the U.S. Food and Drug Administration (USFDA). Zee Entertainment Enterprises gained 2.86% after the company announced a strategic partnership with the new-age content & tech start-up, Bullet, to launch Indias first micro-drama app. Jana Small Finance Bank rose 0.16%. The bank submitted an application to the Reserve Bank of India (RBI) on 9 June 2025, seeking approval for a voluntary transition into a universal bank. Mahindra & Mahindra (M&M) shed 0.65%. The company said that it has increased its stake in Mahindra & Mahindra Financial Services (MMFSL), its listed non-banking finance subsidiary, following the allotment of equity shares under MMFSLs Rs 2,996 crore rights issue. Zydus Lifesciences rose 0.84%. The company announced that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) manufacturing facility located at Dabhasa, near Vadodara. Global Markets: European markets traded lower on Tuesday despite the U.K. unemployment and wage data release. The UK unemployment rate rose to 4.6% in the three months from February to April, marking its highest level since July 2021, according to official data released Tuesday by the Office for National Statistics (ONS). The figure represents a 0.2 percentage point increase compared to the previous three-month period. It also exceeded market estimates, which had forecast an April unemployment rate of 4.5%. The number of unemployed people stood at approximately 1.6 million as of April. Despite the rise in unemployment, the employment rate inched up by 0.1 percentage points to 75.1%, with the total number of employed individuals reaching 34 million. Meanwhile, the economic inactivity ratewhich measures the proportion of the working-age population that is neither employed nor actively seeking workdeclined by 0.2 percentage points to 21.3%. Asian stocks ended mixed as investors awaited further developments from the ongoing U.S.-China trade talks. Trade discussions between the two countries resumed in London on Monday. The U.S. delegation included Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick, and Trade Representative Jamieson Greer, while the Chinese delegation was led by Vice Premier He Lifeng. The talks follow a May agreement to temporarily reduce mutual tariffs. Current discussions are focused on China's export controls on rare earth minerals and U.S. restrictions on semiconductor exports to Chinaboth of which have significant implications for global supply chains. In the U.S., equity market movements were subdued on Monday ahead of the upcoming consumer price index (CPI) inflation data release scheduled for Wednesday. The S&P 500 rose 0.09%, marking its second consecutive gain. The Nasdaq Composite added 0.31%, while the Dow Jones Industrial Average edged down by 1.11 points.
Business Standard
2 days ago
- Business Standard
Zydus receives EIR for the API manufacturing facility at Dabhasa
Zydus Lifesciences has received the EIR report from the USFDA for the inspection conducted at its API manufacturing facility located at Dabhasa near Vadodara. This facility underwent an inspection from 21st to 25th April 2025 and has been classified as Voluntary Action Indicated (VAI). FDA confirmed the inspection as closed. Powered by Capital Market - Live News
